THE newest approach to treating depression
Spravato/esketamine is a revolutionary new insurance covered approach to truly healing major depression!
Spravato/esketamine is a revolutionary new insurance covered approach to truly healing major depression!
2 minute overview of the Spravato treatment process
Depression can be suffocating in the way it affects every aspect of your life, the way it makes even the simplest tasks appear totally unaccomplishable...
Our clinical and support teams understand depression like no else. They do everything possible to make the process smooth and easy on our patients.
From designing a quick online registration, to offering telemedicine evaluations, to fighting with insurance companies on our patient's behalf, we are there for our patients!
In this study, treated patients started doing better than those getting a placebo within 24 hours!
As time passes depression symptoms continue to decrease.
4 year data shows that response to Spravato doesn't fade with time. Patients get better and stay better!
These insurance plans include coverage for Spravato in their policies. Our dedicated insurance coverage team will get your depression care covered and make sure your out-of-pocket costs and expenditures are minimized.
No matter what type of coverage you have – or even if you don’t have coverage – Janssen CarePath can help explain your medication insurance coverage and potential out-of-pocket costs and help find programs that may help you pay for SPRAVATO®.
SPRAVATO™ is taken with a daily oral antidepressant
You administer SPRAVATO™ nasal spray yourself under the supervision of a healthcare professional at a certified SPRAVATO™ treatment center
SPRAVATO™ is taken twice a week for the first four weeks
After the first four weeks, SPRAVATO™ is taken once a week for a month
After this, SPRAVATO™ is usually taken either once a week or once every two weeks
Most major insurances (Aetna, Cigna, Horizon, United, Medicare) cover SPRAVATO™ treatments. Additionally, various support programs from Janssen Pharmaceuticals help patients cover the costs of medication and of administration/observation.
No, administered at small doses in a medical setting, there is no evidence that Spravato is addictive. In contrast, those who abuse ketamine recreationally do so at very high doses to induce psycho-active affects.
No, clinical experience suggests that Spravato is especially effective for patients with treatment-resistant depression, including those who have already tried ECT and/or TMS without benefit. In fact, literature suggeststhat patients MOST resistant to other treatments do best with Spravato.
In clinical studies, improvement of depressive symptoms was demonstrated at four weeks by SPRAVATO® plus an oral antidepressant, compared with placebo nasal spray plus an oral antidepressant. Not all patients will respond to SPRAVATO®. Many patients respond as early as after the first treatment, while others see major improvements after a few months of treatment. Almost everyone leaves their first session more relaxed and less pessimistic about the future!
Some (very few) patients taking SPRAVATO® may experience nausea or vomiting. Because of this, you should avoid eating two hours before, and drinking liquids 30 minutes before, taking SPRAVATO®.
Studies suggest that once improvement is seen, it is sustained over time!
There are no current head-to-head studies comparing the effectiveness of Spravato to IV ketamine infusions. Based on the experience of practitioners using compounded intranasal ketamine vs. IV ketamine infusions, ketamine infusions appear to have more side effects without any additional benefit. Additionally, IV ketamine infusions are NEVER covered by insurance endangering the patients' ability to continue treatment that may be proving beneficial. Spravato, conversely, is almost always covered by health insurance.
Although it is given as an intranasal spray, the FDA has highly regulated Spravato. The FDA has also required that Spravato be administered in the practitioner’s office with a 2 hour post-application monitoring period in the office.
The current recommended treatment protocol is for 2x a week treatment for the 1st 4 weeks, then weekly treatments weeks 5-9. Thereafter, treatment frequency is once every 1-2 weeks. There are now studies demonstrating efficacy of Spravato for over 4 years!
Your blood pressure may rise for a few hours after Spravato administration. We will actively monitor your pressure during your treatments.
Some patients report feeling transiently nauseous. This is usually fairly mild and we have never had a patient get nauseous to the point of vomiting.
Some patients report times during their treatment when they're able to step outside of reality and get a different perspective on the issues central to their depression.
Most patients get a little sleepy during their treatments. Patients relax on a recliner in a softly lit room, under a cozy blanket, listening to music or simply resting.
We have been in clinical practice since 2006 helping patients such as yourself. We are family physicians, embracing complementary and alternative approaches to healing, from Medical Acupuncture to Medical Marijuana, and now Spravato/esketamine.
We have always put patients above profits, and have never compromised patient care to meet some absurd insurance company metrics. Our clinical team is accessible 24/7 to our patients.
Multiple sites - see below!
Monday - Friday
7:45A - 5P